The cofounder and CEO of Neurona Therapeutics discussed the company’s goals to evaluate the cell therapy in more types of epilepsy and potentially even in Alzheimer disease.
Cory R. Nicholas, PhD
Advertisement
Articles by Cory R. Nicholas, PhD
The cofounder and CEO of Neurona Therapeutics discussed results from a phase 1/2 clinical trial presented at AES’s annual meeting.
The cofounder and CEO of Neurona Therapeutics discussed NRTX-1001, the company’s allogeneic regenerative neural cell therapy.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CGTlive®
1
Guess the Therapy Answer October 23, 2025
2
CGTLive®’s Weekly Rewind – October 24, 2025
3
Quarter Century Update: What Were the Most Significant Inflection Points or Breakthroughs in the Field?
4
